Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer - Ultra-HART

NCT06355050 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.

NCT NCT06355050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer - Ultra-HART
Lead sponsor
Jena University Hospital
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2026
Completion date
September 30, 2032
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adaptive radiotherapy, prostate cancer, quality of life